• FluTrackers.com Inc. does not provide medical advice. Information on this web site is collected from various internet resources, and the FluTrackers board of directors makes no warranty to the safety, efficacy, correctness or completeness of the information posted on this site by any author or poster. The information collated here is for instructional and/or discussion purposes only and is NOT intended to diagnose or treat any disease, illness, or other medical condition. Every individual reader or poster should seek advice from their personal physician/healthcare practitioner before considering or using any interventions that are discussed on this website. By continuing to access this website you agree to consult your personal physican before using any interventions posted on this website, and you agree to hold harmless FluTrackers.com Inc., the board of directors, the members, and all authors and posters for any effects from use of any medication, supplement, vitamin or other substance, device, intervention, etc. mentioned in posts on this website, or other internet venues referenced in posts on this website.
  • We are not asking for any donations. Do not donate to any entity who says they are raising funds for us.

Cytokine production in whole-blood cultures following immunization with an influenza vaccine

tetano

Editor, Senior Moderator
Hum Vaccin Immunother. 2018 Jul 23. doi: 10.1080/21645515.2018.1498435. [Epub ahead of print]
[h=1]Cytokine production in whole-blood cultures following immunization with an influenza vaccine.[/h] Nakayama T[SUP]1[/SUP], Kumagai T[SUP]2[/SUP], Kashiwagi Y[SUP]3[/SUP], Yoshii H[SUP]4[/SUP], Honjo K[SUP]4[/SUP], Kubota-Koketsu R[SUP]5[/SUP], Okuno Y[SUP]6[/SUP], Suga S[SUP]7[/SUP].
[h=3]Author information[/h]

[h=3]Abstract[/h] A clinical trial of a quadrivalent split influenza vaccine was performed in the 2014/15 season. Sixty-four subjects aged 6 months to 18 years were enrolled in order to investigate the relationship between cellular and humoral immune responses. Subjects were categorized into two groups by measuring neutralizing antibodies: non-primed na?ve/primed or seroconverted/non-seroconverted groups. Whole-blood cultures were stimulated with the H1N1 split antigen before immunization and one month after the first and second immunizations for subjects < 13 years and before and one month after the first dose for those ≥ 13 years in order to investigate cytokine production. Significant amounts of IL-2, IL-12, IL-13, MCP-1, MIP-1β, and TNF-α were detected from one month after the first dose in the na?ve group. In addition to these cytokines, the production of IL-1β, IL-4, IL-6, IL-8, IL-10, IL-17, G-CSF, and IFN-γ was enhanced one month after the second dose. No significant increase was noted in the primed group, except in the production of IL-10. In seroconverted subjects, the production of IL-2, IL-4, IL-8, IL-10, G-CSF, MCP-1, TNF-α, and IFN-γ increased one month after the first dose, which was earlier than in the na?ve group, whereas no significant cytokine response was noted in subjects without seroconversion. Subjects ≥ 13 years were primed and the production of G-CSF, IL-4, and IL-1β increased in subjects with seroconversion. Whole-blood cultures were also stimulated with the H3N2 split antigen and similar cytokine profiles were obtained. Many cytokines and chemokines, including inflammatory cytokines, were produced in seroconverted, but not non-seroconverted subjects.


[h=4]KEYWORDS:[/h] Influenza vaccine; cytokine profile; inflammatory cytokines: neutralizing antibodies; whole-blood cultures

PMID: 30036123 DOI: 10.1080/21645515.2018.1498435
 
Back
Top Bottom